63833-891 : Riastap 1300 mg/50ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: | 63833-891 |
Labeler: | Csl Behring Gmbh |
Product Type: | Plasma Derivative |
Drug Name: | Riastap |
Dosage Form: | Intravenous Injection, Powder, Lyophilized, for Solution |
Application #: | BLA125317 |
Rev. Date: |
NDC Package Codes:
- 63833-891-51: 1 VIAL, SINGLE‑USE IN 1 CARTON (63833‑891‑51) > 50 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Fibrinogen Human
Dosage Strength:
- 1300 mg/50mL
Pharmaceutical Classes:
- Human Blood Coagulation Factor [EPC]
- Increased Coagulation Activity [PE]
- Blood Coagulation Factors [CS]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 63833-829Next: 63843-465 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.